Jeffrey Olgin
Corporate Officer/Principal chez UCSF School of Medicine
Provenance du réseau au premier degré de Jeffrey Olgin
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
UCSF School of Medicine
7
| College/University | Other Consumer Services | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jeffrey Olgin via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Corporate Officer/Principal | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Stony Brook University | College/University | Doctorate Degree | |
| Harvard College | College/University | Undergraduate Degree | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Founder | |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong and Randy L. Scott. The firm is headquartered in Redwood City, California. | Investment Managers | Private Equity Investor | |
Pr3vent, Inc
 Pr3vent, Inc Medical/Nursing ServicesHealth Services Pr3vent, Inc provides healthcare technology services. The company was founded by Jochen Kumm and Darius M. Moshfegh and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Founder | |
Silk Technologies Ltd.
 Silk Technologies Ltd. Pharmaceuticals: MajorHealth Technology Silk Technologies Ltd. develops silk-derived protein (SDP) products for ophthalmic applications. Its patented SDP material is currently being developed as a compound for the treatment of patients with dry eye disease. The company was founded by Brian D. Lawrence and is headquartered in Plymouth, MN. | Pharmaceuticals: Major | Director/Board Member | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Placid0, Inc.
 Placid0, Inc. Packaged SoftwareTechnology Services Part of Ainsly Ltd., Placid0, Inc. develops a mobile platform for assessing ocular conditions. The company is based in Pasadena, CA. The company was founded in 2020 by Andrew Moshfeghi, Zach Bodnar, Darius M. Moshfeghi, Jochen Kumm, Emmett T. Cunningham. Placid0 was acquired by Ainsly Ltd. on February 10, 2022. | Packaged Software | Founder | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
| BLACKSTONE INC. | Investment Managers | Private Equity Investor | |
| New York University | College/University | Corporate Officer/Principal | |
| Francis I Proctor Foundation | Corporate Officer/Principal | ||
California Pacific Medical Center
 California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
| GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Drexel University | College/University | Undergraduate Degree | |
Ophthalmology Innovation Summit
 Ophthalmology Innovation Summit Financial ConglomeratesFinance Ophthalmology Innovation Summit provides investment services. The private company is based in Jericho. The American company was founded by Emmett T. Cunningham, Gilbert H. Kliman. | Financial Conglomerates | Founder | |
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member | |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of California San Diego | College/University | Doctorate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Sexual Medicine Society of North America | Chairman |
Statistiques
Internationale
| Etats-Unis | 33 |
Sectorielle
| Health Technology | 14 |
| Consumer Services | 9 |
| Finance | 6 |
| Health Services | 3 |
| Technology Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 15 |
| Director/Board Member | 12 |
| Founder | 4 |
| Private Equity Investor | 4 |
| Independent Dir/Board Member | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Emmett Cunningham | 29 |
| Dean Sheppard | 5 |
| Alan Shindel | 2 |
| Matthew State | 1 |
| Paula Braveman | 1 |
| Eleni Linos | 1 |
| James Ostroff | 1 |
- Bourse
- Insiders
- Jeffrey Olgin
- Connexions Sociétés
